{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:02:03Z","timestamp":1791918123345,"version":"4.3.4"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.sxmr.2020.10.003","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T14:46:55Z","timestamp":1605538015000},"page":"464-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Review of Antipsychotics and Priapism"],"prefix":"10.1093","volume":"9","author":[{"given":"Thomas","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejash","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Sadeghi-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2020.10.003_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"issue":"1 Pt 2","key":"10.1016\/j.sxmr.2020.10.003_bib2","first-page":"476","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib3","first-page":"S39","article-title":"Report of the American Foundation for Urologic Disease (AFUD) thought leader panel for evaluation and treatment of priapism","volume":"13 Suppl 5","author":"Berger","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.10.003_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.sxmr.2018.09.002","article-title":"Unintended consequences: a review of pharmacologically-induced priapism","volume":"7","author":"Scherzer","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2020.10.003_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/YIC.0b013e3282f1c1ef","article-title":"Priapism associated with atypical antipsychotic medications: a review","volume":"23","author":"Sood","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/aja.2011.114","article-title":"Medical management of ischemic stuttering priapism: a contemporary review of the literature","volume":"14","author":"Levey","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.sxmr.2020.10.003_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.encep.2013.11.004","article-title":"Priapisme sous antipsychotiques et d\u00e9fis de prise en charge: \u00e0 propos d'un cas [Antipsychotic-induced priapism and management challenges: a case report]","volume":"40","author":"Doufik","year":"2014","journal-title":"Encephale"},{"key":"10.1016\/j.sxmr.2020.10.003_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib9","first-page":"496364","article-title":"Priapism in antipsychotic drug use: a rare but important side effect","volume":"2012","author":"Sinkeviciute","year":"2012","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eurpsy.2004.11.003","article-title":"Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies","volume":"20","author":"Abi-Dargham","year":"2005","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.sxmr.2020.10.003_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib13","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2174\/1570159X15666170630163616","article-title":"Antipsychotic drugs: from receptor-binding profiles to metabolic side effects","volume":"16","author":"Siafis","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/archpsyc.1989.01810030081011","article-title":"Effects of psychotropic drugs on human erection and ejaculation","volume":"46","author":"Segraves","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0196-0644(89)80464-0","article-title":"Priapism: current concepts","volume":"18","author":"O'Brien","year":"1989","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1592\/phco.22.12.1070.33613","article-title":"Priapism associated with two atypical antipsychotic agents","volume":"22","author":"Reeves","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sxmr.2020.10.003_bib17","first-page":"46","article-title":"Drug-induced priapism. Its aetiology, incidence and treatment","volume":"4","author":"Ba\u00f1os","year":"1989","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"10.1016\/j.sxmr.2020.10.003_bib18","first-page":"241573","article-title":"A\u00a0case of priapism with risperidone","volume":"2014","author":"Ginory","year":"2014","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4274\/balkanmedj.2015.1300","article-title":"Olanzapine-induced priapism in a child with Asperger's syndrome","volume":"34","author":"Bozkurt","year":"2017","journal-title":"Balkan Med J"},{"key":"10.1016\/j.sxmr.2020.10.003_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004850-200607000-00008","article-title":"Priapism associated with typical and atypical antipsychotic medications","volume":"21","author":"Wang","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/JCP.0b013e3181c8273d","article-title":"Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity","volume":"30","author":"Andersohn","year":"2010","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12245-010-0175-y","article-title":"Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction","volume":"3","author":"Geraci","year":"2010","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/cap.2004.14.342","article-title":"Occurrence of priapism with risperidone-paroxetine combination in an autistic child","volume":"14","author":"Yang","year":"2004","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2045125312464104","article-title":"Priapism associated with risperidone: a case report, literature review and review of the South London and Maudsley hospital patients' database","volume":"3","author":"Paklet","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S1092852912000351","article-title":"High dosage of aripiprazole induced priapism: a case report","volume":"16","author":"Hsu","year":"2011","journal-title":"CNS Spectr"},{"key":"10.1016\/j.sxmr.2020.10.003_bib26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.aprim.2008.09.030","article-title":"Aripiprazol y priapismo [Aripiprazole and priapism]","volume":"41","author":"Aguilar-Shea","year":"2009","journal-title":"Aten Primaria"},{"key":"10.1016\/j.sxmr.2020.10.003_bib27","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.4088\/JCP.v64n1116e","article-title":"Successful treatment with clozapine at higher doses after clozapine-induced priapism","volume":"64","author":"de Nesnera","year":"2003","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib28","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1176\/appi.ajp.158.12.2087","article-title":"Continuation of clozapine after priapism","volume":"158","author":"Bongale","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.purol.2008.04.010","article-title":"Priapisme sous neuroleptiques. A propos de quatre patients [Priapism associated with antipsychotic medications: a series of four patients]","volume":"18","author":"Brichart","year":"2008","journal-title":"Prog Urol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1176\/ajp.141.6.825a","article-title":"Alpha blockade and priapism","volume":"141","author":"Lawrence","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib31","first-page":"430","article-title":"Psychotropic medication and priapism: a comprehensive review","volume":"51","author":"Thompson","year":"1990","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/070674370404901223","article-title":"Priapism","volume":"49","author":"du Toit","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib33","first-page":"1766","article-title":"New-onset priapism associated with ingestion of terazosin in an otherwise healthy man","volume":"4","author":"Sadeghi-Nejad","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.rcl.2004.01.008","article-title":"Priapism","volume":"42","author":"Sadeghi-Nejad","year":"2004","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.sxmr.2020.10.003_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1592\/phco.22.7.538.33672","article-title":"Citalopram-induced priapism","volume":"22","author":"Dent","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sxmr.2020.10.003_bib36","first-page":"99","article-title":"Interactions between the cytochrome P450 system and the second-generation antipsychotics","volume":"28","author":"Prior","year":"2003","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"10.1016\/j.sxmr.2020.10.003_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4088\/JCP.v60n0709","article-title":"A\u00a0pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A","volume":"60","author":"Bork","year":"1999","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00044011-200019040-00006","article-title":"Risperidone drug monitoring","volume":"19","author":"Odou","year":"2000","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.sxmr.2020.10.003_bib39","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4065\/82.10.1289","article-title":"Association between priapism and concurrent use of risperidone and Ginkgo biloba","volume":"82","author":"Lin","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sxmr.2020.10.003_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003088-199500291-00004","article-title":"Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6","volume":"29 Suppl 1","author":"Ereshefsky","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.sxmr.2020.10.003_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4088\/JCP.v63n0312e","article-title":"Exacerbation of idiopathic priapism with risperidone-citalopram combination","volume":"63","author":"Freudenreich","year":"2002","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4088\/JCP.v62n0210d","article-title":"Priapism associated with polypharmacy","volume":"62","author":"Seger","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00019442-200205000-00021","article-title":"Risperidone-associated priapism in an elderly man","volume":"10","author":"Madhusoodanan","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.jcp.0000196115.01001.04","article-title":"Priapism and quetiapine in an HIV-positive male","volume":"26","author":"Harrison","year":"2006","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1440-1614.2004.01371.x","article-title":"Irreversible priapism during olanzapine and lithium therapy","volume":"38","author":"Jagadheesan","year":"2004","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/104454601317261627","article-title":"Risperidone-induced prolonged erections following the addition of lithium","volume":"11","author":"Owley","year":"2001","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib47","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/01.jcp.0000138779.78633.0c","article-title":"Olanzapine-induced clitoral priapism","volume":"24","author":"Bucur","year":"2004","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ucl.2011.02.005","article-title":"Priapism: new concepts in medical and surgical management","volume":"38","author":"Burnett","year":"2011","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.sxmr.2020.10.003_bib49","first-page":"918","article-title":"Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside","volume":"3","author":"Wen","year":"2006","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib50","first-page":"2152","article-title":"Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism","volume":"5","author":"Muneer","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib51","first-page":"1025","article-title":"Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient","volume":"5","author":"Davila","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib52","first-page":"180","article-title":"Standard operating procedures for priapism","volume":"10","author":"Burnett","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib53","first-page":"114","article-title":"Surgical management of ischemic priapism","volume":"9","author":"Burnett","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib54","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0090-4295(97)00704-8","article-title":"Penile implant for intractable priapism associated with sickle cell disease","volume":"51","author":"Upadhyay","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.10.003_bib55","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.eururo.2008.09.044","article-title":"The immediate insertion of a penile prosthesis for acute ischaemic priapism","volume":"56","author":"Ralph","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib56","first-page":"2300","article-title":"Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion","volume":"183","author":"Salem","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.10.003_bib57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ijir.2011.23","article-title":"Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature","volume":"23","author":"Sedigh","year":"2011","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.10.003_bib58","first-page":"29","article-title":"Successful management of psychotropics induced stuttering priapism with pseudoephedrine in a patient with schizophrenia","volume":"48","author":"Thippaiah","year":"2018","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.sxmr.2020.10.003_bib59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4088\/PCC.08l00666","article-title":"Risperidone-induced priapism: a case report","volume":"11","author":"Sharma","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib60","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1176\/appi.ajp.157.4.659","article-title":"Recurrent priapism during treatment with clozapine and olanzapine","volume":"157","author":"Compton","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.sxmr.2020.10.003_bib61","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ps.55.8.886","article-title":"Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia","volume":"55","author":"Weiden","year":"2004","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.sxmr.2020.10.003_bib62","article-title":"148 Trazodone pre-treatment screening and side effects counseling at a single veterans affairs hospital","volume":"17","author":"Shah","year":"2020","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.10.003_bib63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0033-3182(84)72998-7","article-title":"Priapism in a patient receiving antipsychotic therapy","volume":"25","author":"Griffith","year":"1984","journal-title":"Psychosomatics"},{"key":"10.1016\/j.sxmr.2020.10.003_bib64","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4088\/JCP.v62n0510","article-title":"Priapism associated with conventional and atypical antipsychotic medications: a review","volume":"62","author":"Compton","year":"2001","journal-title":"J\u00a0Clin Psychiatry"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052120301128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052120301128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T19:38:03Z","timestamp":1672774683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052120301128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2050052120301128"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2020.10.003","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of Antipsychotics and Priapism","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2020.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}